KURA
Price
$6.47
Change
-$0.02 (-0.31%)
Updated
May 2 closing price
Capitalization
522.63M
89 days until earnings call
PYXS
Price
$1.26
Change
+$0.16 (+14.55%)
Updated
May 2 closing price
Capitalization
77.6M
6 days until earnings call
Ad is loading...

KURA vs PYXS

Header iconKURA vs PYXS Comparison
Open Charts KURA vs PYXSBanner chart's image
Kura Oncology
Price$6.47
Change-$0.02 (-0.31%)
Volume$1.64M
Capitalization522.63M
Pyxis Oncology
Price$1.26
Change+$0.16 (+14.55%)
Volume$1.29M
Capitalization77.6M
KURA vs PYXS Comparison Chart
Loading...
KURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KURA vs. PYXS commentary
May 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KURA is a StrongBuy and PYXS is a Buy.

Ad is loading...
COMPARISON
Comparison
May 03, 2025
Stock price -- (KURA: $6.47 vs. PYXS: $1.26)
Brand notoriety: KURA and PYXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KURA: 121% vs. PYXS: 224%
Market capitalization -- KURA: $522.63M vs. PYXS: $77.6M
KURA [@Biotechnology] is valued at $522.63M. PYXS’s [@Biotechnology] market capitalization is $77.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.17B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KURA’s FA Score shows that 1 FA rating(s) are green whilePYXS’s FA Score has 1 green FA rating(s).

  • KURA’s FA Score: 1 green, 4 red.
  • PYXS’s FA Score: 1 green, 4 red.
According to our system of comparison, both KURA and PYXS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KURA’s TA Score shows that 5 TA indicator(s) are bullish while PYXS’s TA Score has 5 bullish TA indicator(s).

  • KURA’s TA Score: 5 bullish, 2 bearish.
  • PYXS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, KURA is a better buy in the short-term than PYXS.

Price Growth

KURA (@Biotechnology) experienced а +0.62% price change this week, while PYXS (@Biotechnology) price change was +18.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.30%. For the same industry, the average monthly price growth was +8.07%, and the average quarterly price growth was -4.75%.

Reported Earning Dates

KURA is expected to report earnings on Jul 31, 2025.

PYXS is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (+4.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KURA($523M) has a higher market cap than PYXS($77.6M). PYXS YTD gains are higher at: -19.231 vs. KURA (-25.718). PYXS has higher annual earnings (EBITDA): -64.04M vs. KURA (-169.5M). KURA has more cash in the bank: 727M vs. PYXS (145M). KURA has less debt than PYXS: KURA (16.6M) vs PYXS (20.5M). KURA has higher revenues than PYXS: KURA (53.9M) vs PYXS (16.1M).
KURAPYXSKURA / PYXS
Capitalization523M77.6M674%
EBITDA-169.5M-64.04M265%
Gain YTD-25.718-19.231134%
P/E RatioN/AN/A-
Revenue53.9M16.1M335%
Total Cash727M145M501%
Total Debt16.6M20.5M81%
FUNDAMENTALS RATINGS
KURA: Fundamental Ratings
KURA
OUTLOOK RATING
1..100
27
VALUATION
overvalued / fair valued / undervalued
1..100
29
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KURAPYXS
RSI
ODDS (%)
Bullish Trend 1 day ago
68%
Bearish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 10 days ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
85%
View a ticker or compare two or three
Ad is loading...
KURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FN218.267.50
+3.56%
Fabrinet
MCS16.960.53
+3.23%
Marcus Corp (The)
JPM252.515.62
+2.28%
JPMorgan Chase & Co
FARM1.820.04
+2.25%
Farmer Brothers Company
ENLT16.550.18
+1.10%
Enlight Renewable Energy Ltd

KURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KURA has been closely correlated with PYXS. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if KURA jumps, then PYXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KURA
1D Price
Change %
KURA100%
-0.31%
PYXS - KURA
67%
Closely correlated
+14.55%
BLRX - KURA
43%
Loosely correlated
+0.15%
ZYME - KURA
42%
Loosely correlated
+0.62%
AXON - KURA
41%
Loosely correlated
+1.14%
FATE - KURA
38%
Loosely correlated
+5.65%
More

PYXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PYXS has been closely correlated with KURA. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if PYXS jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYXS
1D Price
Change %
PYXS100%
+14.55%
KURA - PYXS
67%
Closely correlated
-0.31%
BLRX - PYXS
46%
Loosely correlated
+0.15%
ABOS - PYXS
43%
Loosely correlated
+0.93%
BEAM - PYXS
41%
Loosely correlated
+2.07%
CTMX - PYXS
39%
Loosely correlated
+5.90%
More